BrainsWay
Manufacturing · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
16 Hartum St, Jerusalem, Jerusalem, 9777...Phone Number
+97225824030Website
www.brainsway.comRevenue
$49.1 MillionStock Symbol
BWAYIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About BrainsWay
BrainsWay is a global medical technology company specializing in advanced noninvasive neurostimulation solutions for treating mental health and neurological disorders. The company develops and commercializes its proprietary Deep Transcranial Magnetic Stimulation platform, providing innovative treatment technologies for conditions including depression, obsessive-compulsive disorder, smoking addiction, and other psychiatric and neurological disorders. BrainsWay serves healthcare providers, hospitals, and medical centers worldwide, advancing brain health through clinically supported medical device innovation.Explore more
BrainsWay Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BrainsWay your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once BrainsWay has new funding data
Check if BrainsWay has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BrainsWay recently announced quarterly report
Check out if BrainsWay is spiking on competitors!
BrainsWay, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if BrainsWay had a recent Job posting/layoffs
Product Launch: Get notified when BrainsWay launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BrainsWay
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at BrainsWay
Find 2 more new buyers
Company Profile Activity
Activity Insights
BrainsWay is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BrainsWay is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BrainsWay.
BrainsWay financials insights
Gather financial insights about BrainsWay, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Stock/Share Issuance
$20M
BrainsWay Tech Stack
A closer look at the technologies used by BrainsWay
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Person-Based
Medical Research
Person-Based
Healthcare Operations
Person-Based
Healthcare Operations, Medical Administration
Person-Based
Research & Development
BrainsWay News & Media
BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
Record second quarter 2026 revenue increased 35% to $17.1 million, compared with Q2 2025BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026
BURLINGTON, Mass. and JERUSALEM, July 29, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that it will report its second quarter 2026 financial results, as well as operational highlights, before the open of the U.S. financial markets on Wednesday, August 12, 2026. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discussBrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral
Investment further supports BrainsWay's strategy of partnering with growth-oriented mental health providers to raise awareness and expand access to transformative care Investment further supports BrainsWay's strategy of partnering with growth-oriented mental health providers to raise awareness and expand access to transformative careBrainsWay Featured in USA Today America250 Segment Highlighting Future of Mental Health Treatment and Neuromodulation
Advances in neuromodulation are challenging conventional approaches and expanding non‑drug treatment options for depression and other mental health conditions BURLINGTON, MA, UNITED STATES, July 7, 2026 /EINPresswire.com/ -- BrainsWay Ltd. (NASDAQ …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BrainsWay
Sign Up For FreeTo access detailed company insights
BrainsWay is a global medical technology company specializing in advanced noninvasive neurostimulation solutions for treating mental health and neurological disorders. The company develops and commercializes its proprietary Deep Transcranial Magnetic Stimulation platform, providing innovative treatment technologies for conditions including depressi... Read More
